spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  hyperparathyroid 

 HSMN NewsFeed - 10 Dec 2018
Rockwell Medical, Inc. Appoints New Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2018
Rockwell Medical Provides Update on IV Triferic
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2018
Rockwell Medical Appoints VP, Strategic Accounts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2018
Rockwell Medical Appoints New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2017
FDA Approves Amgen's Parsabiv(TM) (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2016
Amgen Provides Update On Status Of Parsabiv(TM) (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Sep 2015
Rockwell Medical Announces the U.S. Commercial Launch of Triferic(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 May 2015
Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2015
ZS Pharma Hires Key Medical Affairs and Commercial Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2013
Rockwell Medical Receives $20 Million in New Financing
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2012
Amgen to Acquire Privately Held KAI Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2011
KAI Pharmaceuticals Signs Agreement for Development and Commercialization of KAI-4169 in Japan with Ono Pharmaceutical
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2011
Cytochroma Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2010
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay
Diagnostics FDA
 HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 May 2010
Teva Announces Tentative Approval of Generic Sensipar(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Nov 2009
Cytochroma Announces Appointment of Peter Moldt to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2007
Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2007
Cytochroma announces appointment of Gordon Ngan, CFA, MBA as Executive Director, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2007
Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical & Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2007
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2007
UK Launch Expands Global Reach of FOSRENOL(R)
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2007
Cytochroma Inc. Announces Completion of $21 Million Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2006
Amgen Announces EVOLVE Trial(TM) To Investigate Impact of Sensipar(R)/Mimpara(R) (cinacalcet HCl) on Mortality and Cardiovascular Morbidity in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease Receiving Dialysis
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 32

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 32 additional stories matching:
hyperparathyroid
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.